ArticleScientific reports2017

Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab.

Hyun Tae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.